Background: The National Institute for Health and Clinical Excellence (NICE) recently released guidelines for the investigation of chest pain of recent onset. There is no published data regarding their impact on out-patient cardiac services. Aim: This study was undertaken to assess the likelihood of coronary artery disease (CAD) in Rapid Access Chest Pain Clinic (RACPC) patients and the resultant investigation burden if NICE guidance was applied. Methods: Five hundred and ninety-five consecutive patients attending two RACPCs over 6 months preceding release of the NICE guidelines [51% male; median age 55 (range 22-94) years] were risk stratified using NICE criteria and the resultant investigations evaluated. Results: One hundred and six (18%) patients had a likelihood of CAD <10%, 123 (21%) between 10% and 29%, 175 (29%) between 30% and 60%, 141
Introduction
Coronary artery disease (CAD) results in over 500 000 out-patient appointments per year in the UK. The cost to the National Health Service (NHS) of these appointments is around £52.2 million. 1 The most common symptom attributable to CAD is chest pain; however, chest pain is often non-cardiac in origin. 2, 3 Rapid Access Chest Pain Clinics (RACPC) have been established in the majority of hospitals across the UK, in accordance with the National Service Framework for Coronary Heart Disease. 4 Their aim is to provide out-patients with suspected cardiac chest pain with prompt investigation and targeted management. Referrals come from general practitioners, consultant cardiologists (when new patients meet the referral criteria) and emergency departments (when patients present with typical symptoms but electrocardiography and troponin levels do not suggest an acute coronary event).
The National Institute for Health and Clinical Excellence (NICE) recently released guidelines for the assessment and diagnosis of recent onset chest pain or discomfort of the suspected cardiac origin. 5, 6 It is envisaged that the guidelines will be used in the out-patient setting by general practitioners and by cardiology specialists in RACPCs. NICE predict the distribution of patients across a spectrum of CAD likelihood, based on the personal communication from two of their authors. 5 They predict around 29% of the patients will have a likelihood <10, 11-17% will have a likelihood 10-29, 17-18% will have a likelihood 30-60%, 15% will have a likelihood 60-90% and 6-9% will have a likelihood >90%.
Likelihood of CAD is determined from patient age, gender and symptoms, with chest pain classified as non-anginal, atypical or typical angina. Within age and sex categories patients are dichotomized to high-or low risk according to whether they have any of diabetes, hyperlipidaemia or a history of smoking (Table 1) . NICE recommend patients with a history of atypical or typical cardiac chest pain and a likelihood of CAD 10-90% should be investigated further ( Figure 1) .
It is vital that the distribution of CAD likelihood predicted by NICE is a true representation of the population utilizing out-patient cardiology services, if this data are to be used for cardiology service planning and implementation of the guidelines across the UK. Emerging evidence suggests that NICE underestimates the number of higher risk patients presenting to emergency departments, RACP services and medical admissions units. 7, 8 If replicated, there will be an increased burden upon non-invasive cardiac imaging and invasive angiography services, with the requirement for additional appropriately trained specialist staff, 9 equipment and financial resources.
Aim
The aim of this study was to assess the potential impact of the NICE chest pain guidelines on referral patterns for cardiac investigations in the UK RACPC setting.
Methods
This study was undertaken in two district general hospitals in London in an attempt to assess an ethnically and socio-economically representative RACPC cohort. Ealing Hospital (EH) lies within a borough of 301 000 people, of whom 58.7% are white with the largest minority group being Indian (16.5%). Chelsea and Westminster Hospital (CWH) lies within a borough of 159 000 people, of whom 78.6% are white with the largest minority population being black African (3.8%). Annual household incomes are among the highest in London in Kensington & Chelsea, while those within wards of Ealing are among the lowest. 10 Consecutive patients attending RACPCs at CWH and EH in the 6 months preceding the release of the NICE chest pain guidelines (September 2009-March 2010) were identified using audit databases at both institutions. Likelihood of CAD was calculated according to NICE criteria (Table 1) using information obtained from patient notes, clinic letters and computer records. Chest pain typicality (based on a history of constricting discomfort, precipitated by exertion and relieved by rest/nitroglycerine) was recorded at the time of consultation for EH patients but determined retrospectively by consensus of two researchers for CWH patients.
Preliminary (i.e. first-line) cardiac investigations recommended by NICE ( Figure 1 ) were compared with those undertaken in the study population. The study sample size was determined using the power calculation method of Nisenn and Schwertman 11 and the null hypothesis 'no difference exists between the distributions of investigations undertaken in the combined hospitals vs. those recommended by NICE'. To achieve a power of 80% required a sample size of 575 patients. Comparisons of the study results were performed using chi-squared and Fisher's exact tests.
Results
Five hundred and ninety-five consecutive cases were identified and reviewed. Full demographical data are shown for each clinic and in combination in Table 2 . The distribution of CAD likelihood according to typicality of symptoms, age, sex and cardiac risk factors is shown for CWH and EH in combination (Table 3) . Age, sex and risk factors were comparable between the two populations; however, the CWH cohort was significantly more likely to report non-anginal pain (P < 0.001).
Overall, 74% of the patients had a modified DF score within the range 10-90%, qualifying them for further investigation. One hundred and six (18%) patients had a likelihood of CAD <10%, 123 (21%) had a likelihood 10-29%, 175 (29%) had a likelihood 30-60%, 141 (24%) had a likelihood 61-90% and 50 (8%) had a likelihood >90%.
There was an increase in the proportion of patients with a likelihood of CAD 10-90% 24-31 percentage points above that predicted by NICE. There was a 4-11 percentage point increase in those with a likelihood 10-29%, an 11-12 percentage point increase in those with a likelihood 30-60% and a 9 percentage point increase in those with a likelihood 61-90%. Applying NICE criteria to the study population would have resulted in no patients recommended for exercise ECG testing (ETT; excluded from the recent guidelines), 10 (2%) recommended for CCT, 69 (12%) for functional cardiac testing and 73 (12%) for invasive angiography (Table 4) . Three hundred and ninety-three (66%) patients would have been excluded from further cardiac investigation by pain classified as non-anginal (287; 48%), a likelihood of CAD <10% (12; 2%) or both (94; 16%). Patients with a likelihood of CAD >90% would also have been excluded bringing the total recommended for no further investigation to 443 (74%).
The distribution of patients recommended for the various preliminary cardiac investigations would have differed significantly from that predicted by NICE for EH, CWH and the combined population (P < 0.001). The distribution would also have differed between the two individual RACPCs (P < 0.001).
Relative to existing clinical practice, applying NICE criteria to the study population would have resulted in a trend towards reduced functional cardiac testing (À24%, P = 0.06). There would have been no significant change in CCT (43%; P = 0.436). Invasive angiography would have increased significantly (508%; P < 0.001) (Figure 2 ). The total number of investigations undertaken would have reduced from 562 to 152 (À73%; P < 0.001), predominantly due to the exclusion of ETT.
Using valuations documented by NICE, costs for preliminary cardiac investigations would 
Discussion
The results of this study suggest that the impact of the NICE guidelines may be greater than predicted by NICE themselves, with an increased proportion of the study population falling within the boundaries of 10-90% likelihood of CAD and potentially eligible for investigation. Furthermore, the distribution of the study patients was skewed towards a higher likelihood of CAD than predicted by NICE, suggesting an increased requirement for functional cardiac testing and invasive coronary angiography. Hospitals implementing the NICE guidelines may, therefore, be advised not to develop cardiac services founded solely upon NICE predictions of likely investigation burden.
Comparison of existing clinical practice with that recommended by NICE demonstrates the actual changes that will be necessary if the guidelines are implemented. Application of the guidelines would have resulted in the discharge without further cardiac investigation of two-thirds of the study population, with pain categorized as non-anginal or a modified DF score <10%. This equates to a percentage increase in discharge without investigation >1000% compared with existing practice. Despite the recognized validity of pre-test probability scoring in the prediction of CAD, 12 many clinicians may be unhappy to discharge patients whom another clinician has deemed at risk of myocardial ischaemia without investigation. In a recent, large, multi-centre study of RACPC attendances, 32% of the significant cardiac events occurred in patients diagnosed with non-cardiac chest pain, highlighting the risk of diagnosis based on clinical judgement alone. 13 Moreover, consultation without progression to investigation may do little to address the concerns and expectations of patients who have been informed they are at risk of ischaemic heart disease. 14 In the study population, ETT was performed as a preliminary investigation in around 85% of EH patients and 65% of CWH patients but would have been recommended for none by NICE. NICE have controversially excluded ETT as a recommended first line investigation due to its relative lack of sensitivity and specificity. Instead, they emphasize the importance of history taking and clinical examination to avoid progression to unwarranted cardiac investigation in patients judged at low risk of CAD. The NICE approach differs significantly from standard UK cardiological practice, in which ETT is used for both the diagnosis and prognostication of CAD.
NICE would have recommended functional cardiac testing for only 60% of those patients currently referred. The number of CCT scans would have increased by 43% but given the persistently small numbers involved, this would not have been statistically significant. The number of patients referred directly for invasive angiography would have risen significantly by over 500%. The authors recognize that this may be an over-estimation since NICE recommend angiography with the caveat that it should be limited to patients for whom revascularization is a consideration and for whom the procedure is clinically appropriate and personally acceptable. If invasive angiography is not performed, NICE recommend functional cardiac testing as an alternative; therefore, functional testing may have been similarly underestimated in this study. Nevertheless, there is concern in the medical literature that the NICE chest pain guideline favours anatomical diagnosis at the expense of functional assessment and thus risks being ignored by UK cardiology. 15 The results suggest that implementation of the NICE guidelines will result in an increased number of patients requiring highly specialized investigations, many of which are not widely available across the NHS. While the majority of NHS hospitals with RACPCs have access to a CT scanner, developing a CCT service (using a minimum standard of a 64-detector scanner), enhancing a local functional imaging service (using stress echocardiography, myocardial perfusion scintigraphy and perfusion cardiac MRI) or expanding invasive angiographic services requires significant investment in equipment, personnel and training. Hospitals may elect to send patients to specialist hubs for these investigations, delaying time to definitive diagnosis and targeted management.
In addition to considering local infrastructure, this study demonstrates that local demographical factors must be taken into account when planning NICE compliant services. Although EH and CWH are within a limited geographical area, and their RACPC patients were similar in number, age and sex, applying NICE criteria would have resulted in significantly different service requirements for each hospital. The high proportion of the CWH cohort with non-anginal chest pain would have resulted in a greater number of these patients being discharged without investigation. In contrast, the EH cohort trended towards having a higher likelihood of CAD and would have been more likely to be recommended for invasive angiography. It may be relevant that the 2001 census established EH has a higher proportion of Asian individuals within its catchment area, whose risk of myocardial infarction and cardiovascular death is increased compared with other ethnic groups. [16] [17] [18] Since the primary determinant of costs presented in this study is local demographic equivalence to the NICE model, it would appear prudent that individual hospitals audit their existing RACPC populations before investing in cardiac services to meet the NICE guidelines. In hospitals where cardiac services are currently insufficient to meet NICE requirements, the costs of establishing the pre-requisite infrastructure will have to be justified economically based on the predicted uptake of investigations.
Conclusions
This is the first study to evaluate the impact of the NICE chest pain guidelines on out-patient cardiac services in the UK, using a large retrospective and representative cohort from two London hospitals. The findings suggest that NICE may have underestimated the likelihood of CAD and hence the burden of cardiac investigation in this population. When compared with existing clinical practice, the effects of implementing the NICE guidelines on cardiac services are likely to be 4-fold. First, the results suggest a significant increase in the number of patients who will be discharged without any cardiac investigation. Second, ETT will no longer be used for the diagnosis of obstructive CAD. Third, there will be a requirement for a CCT service for a small number of patients, which may be difficult to justify economically. Fourth, there may be an overall reduction in demand for functional cardiac testing as it is recommended that the majority of patients undergoing investigation proceed directly to invasive angiography. Individual trusts should assess their local RACPC cohorts if they are considering implementing the NICE guidelines and this should underpin any planned service reconfiguration.
Limitations
While the study was designed to provide a representative sample of UK RACPC attendances, the findings were limited by the fact that the study occurred within a limited geographical area and data were collected retrospectively.
It should be noted that the study only analysed the impact of NICE guidelines on preliminary cardiac investigations and not on subsequent investigations or patient outcomes. Extrapolation of the data to predict overall costs from first patient contact to discharge are therefore not possible. The methodology of the study reflects NICE guidelines, which are focused on diagnosis rather than risk assessment and resultant management. Likewise, NICE economic analyses do not take infrastructure costs into account. The implicit concern is that the NICE model does not reflect clinical practice; however, this is the remit of ongoing research by NICE and others.
